Marc M. Loriaux, M.D.

Head Shot of Marc Loriaux
click here
503 494-6775


Marc Loriaux, M.D., Ph.D. joined the Department of Pathology and Medicine in July, 2003 after completing a fellowship in Hematopathology at OHSU. He will help to staff the diagnostic hematopathology service and continue his research in Dr. Brian Druker’s laboratory studying tyrosine kinases as possible therapeutic targets in the treatment of hematologic malignancies.

Selected Publications

"A case study of personalized therapy for osteosarcoma," Pediatric Blood and Cancer (Vol: 60, Issue: 8, Page 1313-1319) - 2013

"Comparison of methods to identify aberrant expression patterns in individual patients: Augmenting our toolkit for precision medicine," Genome Medicine (Vol: 5, Issue: 11, ) - 2013

"CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway," Leukemia (Vol: 27, Issue: 10, Page 2094-2096) - 2013

"HitWalker: Variant prioritization for personalized functional cancer genomics," Bioinformatics (Vol: 29, Issue: 4, Page 509-510) - 2013

"Imatinib and dasatinib inhibit hemangiosarcoma and implicate PDGFR-β and Src in tumor growth," Translational Oncology (Vol: 6, Issue: 2, Page 158-168) - 2013


Back to faculty list

For Healthcare Professionals


  Email Marc Loriaux

503 494-6775

Memberships & Associations